Delaware
|
000-50590
|
11-3516358
|
||
(State
or Other Jurisdiction of Incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR
240.13e-4(c))
|
REXAHN
PHARMACEUTICALS, INC.
|
|||
(Registrant)
|
|||
By
|
/s/
Tae Heum Jeong
|
||
|
Tae
Heum Jeong
|
||
Chief
Financial Officer
|
Date:
|
June
12, 2006
|